| # | Side effect | Count |
|---|---|---|
| 0 | PYREXIA | 21 |
| 1 | TYPE III IMMUNE COMPLEX MEDIATED REACTION | 21 |
| 2 | ANAEMIA | 20 |
| 3 | OFF LABEL USE | 15 |
| 4 | HAEMOLYSIS | 14 |
| 5 | INFECTION | 11 |
| 6 | BREAKTHROUGH HAEMOLYSIS | 10 |
| 7 | PNEUMONIA | 10 |
| 8 | HEPATIC FUNCTION ABNORMAL | 8 |
| 9 | COVID-19 | 7 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | TYPE III IMMUNE COMPLEX MEDIATED REACTION | 21 | 0.0376 |
| 1 | BREAKTHROUGH HAEMOLYSIS | 10 | 0.0251 |
| 2 | EXTRAVASCULAR HAEMOLYSIS | 6 | 0.0141 |
| 3 | MENINGOCOCCAL BACTERAEMIA | 1 | 0.0104 |
| 4 | PANCREATIC ENZYME ABNORMALITY | 1 | 0.0098 |
| 5 | BILIRUBINURIA | 1 | 0.0095 |
| 6 | COMPLEMENT FACTOR ABNORMAL | 1 | 0.0093 |
| 7 | SUSPECTED DRUG-INDUCED LIVER INJURY | 1 | 0.0050 |
| 8 | PURPURA FULMINANS | 1 | 0.0039 |
| 9 | MENINGOCOCCAL INFECTION | 1 | 0.0032 |